谷歌浏览器插件
订阅小程序
在清言上使用

Long-term Efficacy and Safety Following Switch Between Upadacitinib and Adalimumab in Patients with Rheumatoid Arthritis: 5-Year Data from SELECT-COMPARE

Rheumatology and Therapy(2024)

引用 0|浏览15
关键词
Adalimumab,Efficacy,JAK inhibitor,Long-term extension,Rheumatoid arthritis,TNF inhibitor,Treatment switch,Upadacitinib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要